Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members.
The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles. The works may be submitted in Spanish or English and are subjected to a peer review process.
In 2009, it became the leading Spanish journal in the field of Medical Imaging on having an Impact Factor , awarded by the Journal Citation Reports.

See more

Indexed in:

Science Citation Index Expander, Medline, IME, Bibliomed, EMBASE/Excerpta Medica, Healthstar, Cancerlit, Toxine, Inside Conferences, Scopus

See more

Follow us:

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2021

See more
Impact factor 2021
1.247
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2021
1.4
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2021
0.258
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2021
0.487
View more metrics
Hide
Issue
Vol. 41. Issue 5.
Pages 273-340 (September - October 2022)
Editorial
Are the radiation segmentectomy results in hepatocellular carcinoma reproducible? What factors guarantee success?
Javier Orcajo Rincón, Laura Reguera Berenguer, Juan Carlos Alonso Farto
Rev Esp Med Nucl Imagen Mol. 2022;41:273-4
Original articles
Contribution of 18F-FDG PET/CT imaging in the diagnosis and management of HIV-positive patients
Gamze Tatar, Tevfik Fikret Çermik, Göksel Alçın, Ozge Erol Fenercioglu, Ayşe İnci, Ediz Beyhan, Nurhan Ergül
Rev Esp Med Nucl Imagen Mol. 2022;41:275-83
Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: Combined sentinel node-radioguided surgery of the pathological node
J. Fuertes Manuel, S. Kohan, M. Jordà Solé, I. Mateu Hidalgo, M. Miralles Curto, O. Aguiló Sagristà, E. Aguilar Alomá, K. Peña González, A. Lafuerza Torres, M. Melé Olivé, J. Repkova, M.J. Montero Jaime, J. Gumà Padró
Rev Esp Med Nucl Imagen Mol. 2022;41:284-91
Utility of gastrointestinal transit scintigraphy in the evaluation of chronic constipation
J.R. Infante, A. Baena, A. Martínez, J.I. Rayo, J. Serrano, P. Jiménez, M.C. Lavado
Rev Esp Med Nucl Imagen Mol. 2022;41:292-9
Implementation of the failure modes and effects analysis in a Hospital Radiopharmacy Unit
I. Romero-Zayas, F. Campos Añón, M. Santos Virosta, J. Cordón del Pozo, C. Santos Montero, A. Niñerola Baizán, D. Fuster
Rev Esp Med Nucl Imagen Mol. 2022;41:300-10
Interesting images
Histoplasmosis in the differential diagnosis of hypermetabolic adrenal masses in 18F-FDG PET/CT
P.J. Plaza López, G. Parini, E. Martinez Miralles, Y. Aguilar Puente
Rev Esp Med Nucl Imagen Mol. 2022;41:314-6
Usefulness of PET/CT in the diagnosis of vascular prosthesis infection: Case report
M. de la Rubia-Marcos, P. García-Alonso, B. Tagliatori-Nogueira, B. Manzarbeitia-Arroba, M. Álvarez-Moreno, M.Á. Balsa-Bretón
Rev Esp Med Nucl Imagen Mol. 2022;41:317-8
18F-FDG PET/CT role in Pott disease
A. Cardozo-Saavedra, S. Ortiz, F.J. Alvarez Moro, P. Bassa, E. Carrillo-Villamizar, J.R. Garcia Garzón
Rev Esp Med Nucl Imagen Mol. 2022;41:319-21
Synergic role of dual tracer PET/CT with 18F-FDG and 68Ga-PSMA in the detection of papillary renal cell carcinoma recurrence
Donatello Gasparro, Maura Scarlattei, Roberta Manuguerra, Priscilla Guglielmo, Silvia Migliari, Antonino Sammartano, Giorgio Baldari, Umberto Maestroni, Livia Ruffini
Rev Esp Med Nucl Imagen Mol. 2022;41:322-4
Follicular thyroid carcinoma arising in a struma ovarii and femoral metastasis
A.G. Castillo Simón, C.V. Martínez Ramos, V.V. Rodríguez Morales, B. Núñez Arana, I. Dominguez Prado, J.L. Muñoz Iglesias
Rev Esp Med Nucl Imagen Mol. 2022;41:325-6
Siliconomes as an incidental finding in an 18F-FDG PET/CT study at follow-up of colon cancer
C. Sandoval-Moreno, M.B. Tagliatori-Nogueira, M. de la Rubia-Marcos, B. Manzarbeitia-Arroba, M. Álvarez-Moreno, M.A. Balsa-Bretón
Rev Esp Med Nucl Imagen Mol. 2022;41:327-8
The significant role of multimodality imaging with 18Fluorocholine PET/CT in relapsed intracranial hemangiopericytoma
A. Sardaro, C. Ferrari, P. Mammucci, D. Piscitelli, D. Rubini, N. Maggialetti
Rev Esp Med Nucl Imagen Mol. 2022;41:329-31
Special collaboration
ImmunoPET in oncology
Francisca Mulero Aniorte
Rev Esp Med Nucl Imagen Mol. 2022;41:332-9
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos